Literature DB >> 21207200

Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches.

Lynne T Shuster1, Stephanie S Faubion, Richa Sood, Petra M Casey.   

Abstract

Menstrual migraine and other hormonally related headaches are common in women. Falling estrogen levels or estrogen withdrawal after periods of sustained higher levels can trigger migraine. It makes sense to target this trigger for management of hormonally related headaches, particularly when nonhormonal strategies have been unsuccessful. Decision making regarding the use of hormonal contraception and menopausal hormone therapy is complex and commonly driven by other factors, but hormonal manipulation can potentially improve the course of migraine. Providers caring for migraineurs are appropriately concerned about stroke risk. Estrogen-containing hormonal contraceptives are relatively contraindicated for women who have migraine with aura. Postmenopausal hormone therapy is acceptable for women with a history of migraine. For these women, transdermal estradiol is recommended. Estrogen replacement is important for women who undergo an early menopause, whether natural or induced. Practical strategies for hormonal manipulation in the management of migraine and other hormonally related headaches are presented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207200     DOI: 10.1007/s11910-010-0174-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  44 in total

Review 1.  Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review.

Authors:  Elizabeth W Loder; Dawn C Buse; Joan R Golub
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

Review 3.  Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I.

Authors:  Vincent T Martin; Michael Behbehani
Journal:  Headache       Date:  2006-01       Impact factor: 5.887

4.  Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.

Authors:  Christel Renoux; Sophie Dell'aniello; Edeltraut Garbe; Samy Suissa
Journal:  BMJ       Date:  2010-06-03

5.  Migraine prevalence by age and sex in the United States: a life-span study.

Authors:  T W Victor; X Hu; J C Campbell; D C Buse; R B Lipton
Journal:  Cephalalgia       Date:  2010-03-12       Impact factor: 6.292

Review 6.  Neuroactive properties of reproductive steroids.

Authors:  Andrew G Herzog
Journal:  Headache       Date:  2007-09       Impact factor: 5.887

7.  Increased cardiovascular mortality after early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Robert D Brown; Véronique L Roger; L Joseph Melton; Walter A Rocca
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953

8.  Oral contraceptives and increased headache prevalence: the Head-HUNT Study.

Authors:  K Aegidius; J-A Zwart; K Hagen; B Schei; L J Stovner
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

9.  Premature menopause is associated with increased risk of cerebral infarction in Japanese women.

Authors:  Yosuke Baba; Shizukiyo Ishikawa; Yoko Amagi; Kazunori Kayaba; Tadao Gotoh; Eiji Kajii
Journal:  Menopause       Date:  2010 May-Jun       Impact factor: 2.953

Review 10.  Hormonal therapies for menstrual migraine.

Authors:  Anne H Calhoun; Susan Hutchinson
Journal:  Curr Pain Headache Rep       Date:  2009-10
View more
  12 in total

1.  Clinical pearls in women's health.

Authors:  Lynne T Shuster; John B Bundrick; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

Review 2.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

3.  Sex differences in the inflammatory mediator-induced sensitization of dural afferents.

Authors:  N N Scheff; M S Gold
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

Review 4.  Transdermal hormonal therapy in perimenstrual migraine: why, when and how?

Authors:  Cristina Tassorelli; Rosaria Greco; Marta Allena; Erica Terreno; Rossella E Nappi
Journal:  Curr Pain Headache Rep       Date:  2012-10

Review 5.  Sex-related differences in migraine.

Authors:  Cinzia Finocchi; Laura Strada
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

6.  Cerebrovascular reactivity after cessation of menopausal hormone treatment.

Authors:  J N Barnes; R E Harvey; N A Eisenmann; K B Miller; M C Johnson; S M Kruse; B D Lahr; M J Joyner; V M Miller
Journal:  Climacteric       Date:  2019-01-21       Impact factor: 3.005

Review 7.  Migraine in menopausal women: a systematic review.

Authors:  Patrizia Ripa; Raffaele Ornello; Diana Degan; Cindy Tiseo; Janet Stewart; Francesca Pistoia; Antonio Carolei; Simona Sacco
Journal:  Int J Womens Health       Date:  2015-08-20

8.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

9.  Progesterone and Allopregnanolone Rapidly Attenuate Estrogen-Associated Mechanical Allodynia in Rats with Persistent Temporomandibular Joint Inflammation.

Authors:  Rebecca S Hornung; William L Benton; Sirima Tongkhuya; Lynda Uphouse; Phillip R Kramer; Dayna Loyd Averitt
Journal:  Front Integr Neurosci       Date:  2020-05-08

10.  17-β-Estradiol induces spreading depression and pain behavior in alert female rats.

Authors:  Alexander J Sandweiss; Karissa E Cottier; Mary I McIntosh; Gregory Dussor; Thomas P Davis; Todd W Vanderah; Tally M Largent-Milnes
Journal:  Oncotarget       Date:  2017-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.